Development of Severe Hyperparathyroidism Despite Short-Term Renal Replacement Therapy

Area of Science:

• Nephrology
• Endocrinology
• Surgical Pathology

Background:

• Severe secondary hyperparathyroidism (SHPT) necessitating parathyroidectomy (PTX) can occur even after short-term renal replacement therapy (RRT).
• The specific characteristics and underlying pathophysiology of SHPT in patients undergoing short-term RRT remain underexplored.

Purpose of the Study:

• To elucidate the pathophysiology of severe SHPT in patients who underwent PTX despite short-term RRT.
• To compare the clinical characteristics and outcomes of patients with SHPT who received short-term RRT versus long-term RRT.

Main Methods:

• Retrospective analysis of clinical data from 1013 patients who underwent PTX for severe SHPT between 2007 and 2016.
• Patients were categorized into a short RRT group (≤1 year) and a long RRT group (≥10 years).
• Comparison of patient demographics, primary kidney disease, predialysis duration, preoperative biochemical data, parathyroid gland characteristics, and bone lesion incidence.

Main Results:

• The short RRT group had a higher prevalence of congenital/hereditary kidney diseases and significantly longer predialysis periods compared to the long RRT group.
• Patients in the short RRT group exhibited lower serum calcium and phosphate levels, heavier parathyroid glands, and a greater incidence of severe bone lesions.
• These findings suggest a distinct clinical profile for SHPT in the context of short-term RRT.

Conclusions:

• Severe SHPT requiring PTX after short-term RRT is strongly associated with prolonged chronic kidney disease (CKD) duration prior to RRT initiation.
• Early management of mineral and bone disorders during the early stages of CKD may be crucial in preventing the development of severe SHPT before RRT is initiated.